No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
219 |
4. Check minimum number of eventsNone |
219 |
5. Include endpointsNone |
219 |
6. Filter based on genotype QC (FinnGen only) |
219 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum cerebri non specificatum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Brain, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Brain, unspecified
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2424 | 1453 | 938 |
| Only index persons | 1513 | 913 | 600 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.03 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 48.74 | 51.26 | 44.54 |
| Only index persons | 42.00 | 45.00 | 37.43 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 219 | 137 | 82 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | 41.78 | 41.18 | 42.78 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 203
- Matched controls
- 2031
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
+∞
104.4
91
*
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
72.3
65
*
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
57.0
52
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
13.3
37.4
70
77
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
224.7
37.1
37
*
2152
FHL
Extraction, big brain
+∞
35.5
33
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
14.9
31.3
54
48
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
38.1
27.9
35
11
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
43.4
27.1
33
9
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
85.7
21.2
23
*
N03AF01
ATC
carbamazepine; oral, rectal
9.0
18.3
40
54
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
104.3
17.9
19
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
28.5
17.3
23
9
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
16.9
16
*
N03AB02
ATC
phenytoin; systemic
29.0
15.9
21
8
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
23.2
15.0
21
10
N03AF02
ATC
oxcarbazepine; oral
10.0
14.0
28
32
E23.00
ICD-10 Finland
Panhypopituitarism
57.5
14.0
16
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
20.0
13.7
20
11
101
Kela drug reimbursment
Anterior pituitary hypofunction
43.2
13.4
16
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
12.8
13.2
23
20
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
30.7
13.2
17
6
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
34.5
12.8
16
5
D33.30
ICD-10 Finland
Acoustic neuroma
40.2
12.4
15
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.6
11.6
21
20
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
11.6
11
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
126.8
11.5
12
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.9
11.2
38
91
XCK00
NOMESCO Finland
Perimetry
5.8
10.9
31
61
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
+∞
10.5
10
*
H02AB09
ATC
hydrocortisone; systemic
10.8
9.7
18
18
N03AX14
ATC
levetiracetam; systemic
10.8
9.7
18
18
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
104.7
9.5
10
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
104.7
9.5
10
*
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
+∞
9.4
9
*
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
52.3
8.8
10
*
H53.4
ICD-10 Finland
Visual field defects
9.6
8.7
17
19
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
28.9
8.6
11
*
H47.2
ICD-10 Finland
Optic atrophy
+∞
8.4
8
*
2151
FHL
Resection, big brain
+∞
8.4
8
*
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
34.9
8.2
10
*
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
83.0
7.5
8
*
N05BA09
ATC
clobazam; oral
83.0
7.5
8
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
+∞
7.3
7
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.9
7.1
29
84
G93.0
ICD-10 Finland
Cerebral cysts
41.5
6.8
8
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
23.4
6.7
9
*
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
72.0
6.5
7
*
N03AG01
ATC
valproic acid; systemic, rectal
4.6
6.3
21
50
9161/1-C71.6
ICD-O-3
Hemangioblastoma of cerebellum, NOS
+∞
6.3
6
*
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
+∞
6.3
6
*
D32.03
ICD-10 Finland
Benign meningioma in ventricles
+∞
6.3
6
*
183
Kela drug reimbursment
Lamotrigin and topiramate
27.6
6.3
8
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
12
9.60
9.05
1.5
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
17
6.76
6.84
1.5
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
38
4.16
5.54
1.3
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
115
816
1.86
4.86
7.0
6.9
mmol/l
1.2
1.2
0.04
103
693
(3013826) Glucose [Moles/volume] in Serum or Plasma
133
1009
1.81
4.33
5.2
5.0
mmol/l
6.5
6.7
0.32
128
937
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
104
750
1.74
3.90
6.2
6.0
mmol/l
1.2
1.2
0.16
99
682
(3003396) Base excess in Arterial blood by calculation
35
183
2.09
3.54
8.5
9.5
mmol/l
2.1
1.1
1.04
27
151
(3035637) Corticotropin [Mass/volume] in Plasma
8
15
5.49
3.22
1.4
1.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
16
5.15
3.08
1.3
1.2
nmol/l
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
22
4.22
2.91
2.7
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
9
6.81
2.88
1.0
1.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
22
105
2.22
2.80
4.9
7.6
%
1.3
1.5
0.63
22
105
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
92
2.29
2.77
2.0
2.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
14
5.13
2.75
1.3
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
64
441
1.64
2.66
3.8
4.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
21
104
2.13
2.45
5.1
7.9
%
0.7
0.7
0.19
21
104
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
98
2.15
2.40
5.0
4.8
mmol/l
24.1
24.5
0.23
20
98
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
22
3.73
2.39
1.1
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
23
121
2.01
2.31
5.2
8.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
23
3.57
2.29
1.1
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
8
23
3.57
2.29
1.6
1.5
nmol/l
0.2
0.4
—
8
18
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
18
3.98
2.27
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
18
3.98
2.27
1.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
19
3.77
2.17
1.6
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
14
4.37
2.16
1.3
1.4
mmol/l
2.3
1.9
—
6
14
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
20
3.58
2.07
1.1
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
98
779
1.47
2.05
3.6
4.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
181
1.76
2.01
1.7
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
40
262
1.64
2.00
1.7
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
33
2.80
1.95
1.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
21
114
1.93
1.95
3.7
3.4
ng/l
79.0
74.9
0.15
21
104
(3019309) Folate [Moles/volume] in Red Blood Cells
47
324
1.57
1.92
1.8
1.7
nmol/l
1439.3
1249.5
0.56
38
248
(40768793) Breast Pathology biopsy report
0
52
0.00
1.91
0.0
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
71
537
1.48
1.89
2.2
2.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
12
4.24
1.83
1.4
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
31
195
1.69
1.81
4.7
6.5
mmol/l
102.7
104.0
0.57
31
189
(3026008) Bacteria identified in Urine by Culture
70
535
1.45
1.75
3.4
3.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
134
1.80
1.74
2.3
2.6
ml/min/173m2
65.0
63.6
—
10
57
(3007164) IgA [Mass/volume] in Serum or Plasma
25
393
0.59
1.71
1.4
1.4
g/l
2.1
2.5
0.92
17
239
(3020891) Body temperature
14
69
2.10
1.68
5.1
3.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
173
0.44
1.67
1.9
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
105
870
1.40
1.66
7.3
5.6
e9/l
0.0
0.0
1.16
91
757
(3018418) pH of Serum or Plasma
67
513
1.44
1.65
3.6
3.8
ph
7.4
7.4
0.21
12
97
(3019150) Specific gravity of Urine by Refractometry
53
388
1.48
1.64
5.5
4.3
kg/l
1.0
1.0
0.03
13
47
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
150
1324
1.42
1.62
5.4
4.0
pmol/l
14.8
14.7
0.17
138
1197
(3001604) Monocytes [#/volume] in Blood
104
865
1.39
1.59
7.3
5.6
e9/l
0.6
0.6
2.02
90
752
(1761868) Lipid panel - Serum or Plasma
49
652
0.68
1.58
2.8
2.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
106
885
1.38
1.58
7.3
5.7
e9/l
1.8
1.9
0.81
94
786
(3012544) pH of Venous blood
24
147
1.71
1.55
3.0
3.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
21
2.91
1.51
1.0
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
82
662
1.38
1.48
7.0
8.5
inr
1.2
1.2
0.20
23
199
(3013115) Eosinophils [#/volume] in Blood
106
893
1.36
1.46
7.5
6.1
e9/l
0.2
0.2
0.50
92
787
(3052851) Hemolysis interference index of Serum or Plasma
10
46
2.23
1.42
1.6
3.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
87
713
1.37
1.42
2.4
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
184
1.60
1.40
1.7
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
193
0.50
1.37
1.9
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
53
402
1.42
1.36
2.1
2.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
85
698
1.36
1.36
3.1
2.2
nmol/l
78.3
76.6
0.20
80
618
(4035726)
23
145
1.65
1.35
1.2
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
21
131
1.67
1.29
1.9
3.1
e9/l
66.9
69.9
0.12
16
102
(3019550) Sodium [Moles/volume] in Serum or Plasma
189
1768
1.50
1.26
20.2
16.0
mmol/l
139.3
139.7
0.99
184
1719
(3002256) Pathology report gross observation
31
215
1.51
1.25
1.5
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
50
2.05
1.18
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
14
80
1.80
1.16
13.7
14.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
202
1.50
1.15
5.1
4.6
%
34.0
32.2
0.37
23
132
(3022096) Basophils/100 leukocytes in Blood
93
790
1.31
1.14
7.4
5.9
%
0.7
0.7
0.10
86
727
(3019069) Monocytes/100 leukocytes in Blood
96
821
1.30
1.12
8.1
6.1
%
9.2
8.6
0.84
89
764
(3023103) Potassium [Moles/volume] in Serum or Plasma
189
1779
1.46
1.10
19.9
16.0
mmol/l
4.0
4.0
0.26
184
1728
(3007853) Bacteria identified in Skin by Aerobe culture
27
187
1.51
1.10
1.4
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
16
97
1.70
1.10
2.4
3.8
mmol/l
0.9
1.2
—
6
75
(3026389) Candida sp identified in Specimen by Organism specific culture
5
21
2.41
1.09
1.6
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
51
399
1.36
1.09
1.8
2.0
mg/l
3.3
3.1
0.15
41
359
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
185
1736
1.42
1.09
16.8
14.0
mg/l
25.3
21.3
0.72
153
1346
(3002030) Lymphocytes/100 leukocytes in Blood
97
835
1.29
1.06
7.7
5.9
%
26.9
27.7
0.31
91
772
(3006504) Eosinophils/100 leukocytes in Blood
95
816
1.29
1.06
7.7
5.8
%
2.9
2.7
0.27
87
754
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
66
540
1.32
1.05
3.5
2.4
u/l
56.3
54.8
0.16
60
503
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
46
2.00
1.05
1.2
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
68
559
1.31
1.05
8.2
5.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
22
2.30
1.04
1.4
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
22
2.30
1.04
5.8
3.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
76
1.76
1.01
3.2
4.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
35
459
0.72
1.01
1.9
2.8
umol/l
331.0
6439.9
1.94
29
392
(3018010) Neutrophils/100 leukocytes in Blood
96
830
1.28
1.00
7.3
5.7
%
57.3
57.3
0.00
90
773
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
23
2.20
0.98
1.2
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
45
351
1.35
0.98
2.4
2.6
mosm/kgh2o
537.5
541.3
0.03
35
294
(3011397) Hemoglobin [Presence] in Urine by Test strip
48
381
1.33
0.94
5.8
3.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
17
110
1.59
0.94
12.5
7.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
10
55
1.86
0.93
4.4
3.0
mmol/l
3.6
3.9
—
10
50
(3029937) Albumin [Presence] in Urine by Test strip
58
475
1.30
0.91
5.7
4.2
estimate
0.0
0.0
0.00
11
173
(40761535) Cells panel - Urine sediment
21
144
1.51
0.91
3.4
3.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
46
366
1.33
0.89
2.7
2.4
e6/l
8.7
5.2
0.79
39
319
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
80
686
1.26
0.88
3.6
3.9
ng/l
20.3
40.4
1.92
60
471
(40758558) Short blood count panel - Blood
55
451
1.29
0.86
6.8
7.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
57
1.79
0.85
2.1
2.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
13
199
0.63
0.83
1.4
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
149
0.59
0.82
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
45
364
1.30
0.78
1.7
1.8
pmol/l
462.4
473.5
0.11
34
304
(3017143) Hepatitis C virus Ab [Presence] in Serum
26
195
1.38
0.73
1.2
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
20
143
1.44
0.73
2.8
4.3
%
1.8
0.8
—
6
46
(3012095) Magnesium [Moles/volume] in Serum or Plasma
34
267
1.32
0.72
3.0
4.2
mmol/l
0.8
0.8
0.96
34
247
(3000494) Fungus identified in Specimen by Culture
26
198
1.36
0.68
2.0
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
86
1.54
0.67
1.9
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
111
1010
1.20
0.65
9.3
9.4
e9/l
4.4
4.0
0.76
98
881
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
200
1.34
0.64
11.4
7.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
29
1.74
0.64
1.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
12
79
1.55
0.64
1.2
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
128
1182
1.20
0.64
5.8
4.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
71
1.58
0.63
2.2
1.6
—
—
—
0
0
(3013512) EKG study
60
516
1.22
0.63
4.6
3.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
50
1.62
0.62
1.6
2.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
10
64
1.59
0.59
1.2
2.2
g/l
1.6
1.6
—
10
54
(3003458) Phosphate [Moles/volume] in Serum or Plasma
25
194
1.33
0.59
4.5
6.2
mmol/l
1.0
1.0
0.12
25
174
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
53
1.53
0.59
1.3
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
36
1.68
0.57
1.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
107
1.43
0.57
2.4
2.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
57
493
1.21
0.56
2.6
3.5
ng/l
1093.3
1393.9
0.43
50
416
(3035350) Ketones [Presence] in Urine by Test strip
95
862
1.18
0.56
4.9
3.9
estimate
0.0
0.0
0.00
13
174
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
158
0.68
0.55
1.3
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
182
1.29
0.49
1.7
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
77
695
1.17
0.47
5.1
3.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
49
1.44
0.46
1.0
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
60
533
1.17
0.45
3.4
2.9
e6/l
22.1
163.4
0.60
47
405
(40768797) Stomach Pathology biopsy report
20
250
0.78
0.44
1.5
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
94
866
1.15
0.43
6.1
5.1
estimate
0.0
0.0
0.00
13
175
(3021440) Promyelocytes/100 leukocytes in Blood
17
131
1.32
0.43
2.5
4.5
%
0.2
0.2
—
5
40
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
31
1.63
0.43
2.6
2.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
31
1.63
0.43
1.4
2.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
57
1.42
0.42
2.8
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
69
623
1.16
0.42
3.5
2.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
95
878
1.14
0.42
4.9
3.8
estimate
0.0
0.0
0.00
13
168
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
114
1.34
0.42
1.1
1.5
—
—
—
0
0
(3019225) pH of Specimen
19
150
1.29
0.42
2.8
4.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
11
149
0.72
0.41
5.4
3.9
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
33
1.53
0.41
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(4034850)
8
60
1.35
0.40
12.0
11.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
102
0.68
0.40
1.0
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
35
1.44
0.39
1.0
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
67
1.36
0.38
1.4
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
33
282
1.20
0.38
3.1
2.5
e6/l
0.3
1.0
2.55
16
161
(36304419) Bacteria [Presence] in Urine
53
473
1.16
0.37
3.5
2.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
42
1.44
0.36
1.5
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
123
1294
0.89
0.35
4.9
4.1
mm/h
12.0
11.4
0.21
117
1189
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
169
1633
1.15
0.35
14.3
12.8
ml/min/173m2
84.4
81.9
0.77
142
1330
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
316
0.83
0.34
1.3
1.3
iu/ml
74.1
30.4
—
10
109
(3015736) pH of Urine
74
683
1.13
0.32
5.0
3.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
6
47
1.28
0.32
7.5
3.5
mg/l
1.3
1.6
—
6
42
(3021589) Normoblasts [#/volume] in Blood
83
772
1.12
0.32
10.1
9.6
e9/l
0.0
0.0
0.75
64
626
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
96
0.72
0.31
1.4
2.0
—
—
—
0
0
(3000492) Spirometry study
19
157
1.23
0.30
1.8
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
50
452
1.14
0.30
2.9
3.2
mg/l
27.1
185.8
0.58
31
287
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
28
242
1.18
0.30
1.2
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
28
242
1.18
0.30
2.1
2.2
g/l
2.2
2.3
0.88
28
227
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
27
311
0.85
0.29
1.4
1.3
u/ml
16.4
10.8
0.20
12
130
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
119
0.75
0.28
1.2
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
8
63
1.28
0.28
5.0
1.6
ug/l
4.5
5.0
—
8
56
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
65
1.24
0.27
1.5
1.8
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
5
72
0.69
0.26
2.4
2.0
mg/l
5.0
3.7
—
5
55
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
74
0.67
0.26
1.6
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
81
0.73
0.24
1.3
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
50
459
1.12
0.24
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
168
0.82
0.23
2.4
3.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
38
1.32
0.23
1.0
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
47
511
0.90
0.23
3.6
3.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
40
1.26
0.22
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
11
0.00
0.21
0.0
1.5
—
25.8
—
0
11
(3051651) Icteric interference index of Serum or Plasma
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
10
0.00
0.21
0.0
2.2
—
12.5
—
0
10
(3000330) Specific gravity of Urine by Test strip
11
89
1.25
0.21
3.6
3.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
119.7
—
0
12
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
36
327
1.12
0.21
3.0
3.8
ng/l
17.0
253.5
1.69
29
251
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
80
1.26
0.21
2.9
2.4
%
1.5
1.2
—
10
80
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
13
108
1.22
0.20
1.3
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.7
—
17.0
—
0
14
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
14
0.00
0.20
0.0
2.7
—
566.3
—
0
7
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
166
1696
0.91
0.19
4.8
4.4
mmol/l
1.5
1.5
0.00
159
1571
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
162
1582
1.09
0.19
5.7
5.7
mmol/mol
39.5
39.9
0.18
151
1482
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
176
1.15
0.18
1.2
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
163
1595
1.09
0.17
5.7
4.8
mu/l
1.6
1.9
2.41
148
1447
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
61
1.15
0.17
1.9
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
167
1703
0.92
0.17
4.7
4.5
mmol/l
4.7
4.7
0.25
157
1585
(4010399)
15
129
1.17
0.17
1.9
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
39
421
0.91
0.17
1.3
1.3
u/ml
0.9
1.5
0.47
14
118
(3027944) Amphetamines [Presence] in Urine
5
66
0.75
0.17
1.0
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
69
0.72
0.17
3.4
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
195
1925
1.12
0.16
24.8
20.4
e9/l
255.9
251.1
0.48
190
1876
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
265
1.11
0.15
3.2
2.7
e6/l
1.9
3.3
0.49
12
145
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
161
1641
0.93
0.15
4.3
4.0
mmol/l
1.3
1.3
0.66
154
1511
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
171
1739
0.92
0.15
5.1
4.9
mmol/l
2.8
2.8
0.04
158
1609
(3026361) Erythrocytes [#/volume] in Blood
195
1926
1.11
0.15
24.8
20.4
e12/l
4.4
4.5
0.89
189
1866
(3010813) Leukocytes [#/volume] in Blood
195
1926
1.11
0.15
24.8
20.4
e9/l
6.6
6.6
0.07
190
1868
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
41
385
1.08
0.13
1.7
1.8
mg/l
1.3
1.1
0.14
25
302
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
137
1341
1.06
0.12
8.2
7.3
u/l
76.7
76.7
0.01
131
1258
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
70
673
1.06
0.12
2.3
1.9
pmol/l
95.3
98.4
0.23
42
342
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
13
115
1.14
0.11
2.7
3.5
ng/l
71.5
210.2
2.80
13
103
(3001122) Ferritin [Mass/volume] in Serum or Plasma
78
755
1.05
0.10
2.7
2.6
ug/l
125.7
100.4
0.75
70
701
(40760892) CBC W Ordered Manual Differential panel - Blood
43
409
1.06
0.10
4.4
4.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
45
1.11
0.10
1.0
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
46
1.09
0.09
1.0
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
13
116
1.13
0.09
2.0
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
47
1.07
0.09
1.6
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
48
1.04
0.09
1.0
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
156
1582
0.95
0.09
17.1
14.6
%
39.7
40.2
0.34
103
1192
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
97
1.14
0.09
1.1
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
1.5
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
186
1842
1.06
0.08
11.8
10.3
u/l
26.0
25.9
0.04
178
1783
(3016879) Cocaine [Presence] in Urine
5
64
0.78
0.08
1.0
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
65
0.76
0.08
1.0
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
35
333
1.06
0.08
1.2
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
67
1.05
0.08
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
183
1813
1.06
0.07
15.7
12.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
91
0.87
0.07
1.5
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
116
1179
0.97
0.06
5.3
3.1
u/l
58.7
44.9
1.10
110
1103
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
47
455
1.04
0.06
1.7
1.7
mmol/l
1.9
1.4
1.80
42
381
(3044889) 12 lead EKG panel
118
1196
0.97
0.05
3.8
3.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
50
486
1.04
0.05
3.3
4.0
mg/mmol
4.1
6.3
0.51
31
310
(3018095) Leukocytes [#/volume] in Urine
64
626
1.03
0.04
4.2
3.5
e6/l
20.7
54.4
2.04
50
439
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
110
1114
0.97
0.04
2.6
3.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
19
180
1.06
0.04
1.3
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
51
498
1.03
0.04
2.9
3.0
mmol/l
7.4
7.6
0.10
44
427
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
27
280
0.96
0.03
3.4
2.8
ug/l
0.8
0.8
0.08
21
169
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
290
1.04
0.03
1.7
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
10
108
0.92
0.03
1.3
2.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
50
490
1.03
0.02
3.8
2.7
e6/l
0.4
0.3
0.10
38
360
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
101
0.99
0.00
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
149
1.01
0.00
1.3
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
30
299
1.00
0.00
1.4
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
166
1659
1.00
0.00
4.8
4.6
mmol/l
5.7
6.0
1.98
156
1524
(3002385) Erythrocyte distribution width [Ratio]
144
1442
1.00
0.00
18.4
17.3
%
13.7
13.7
0.10
137
1419
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
37
365
1.02
0.00
4.6
4.1
%
22.4
21.0
0.25
19
167
(3042936) Bacteria identified in Isolate by Culture
24
235
1.02
0.00
3.0
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
9.7
—
0
8
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
56
0.89
0.00
1.2
1.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
8
0.00
0.00
0.0
2.1
—
0.2
—
0
8
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
60
1.00
0.00
1.8
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
49
1.02
0.00
2.8
4.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
94
0.96
0.00
1.2
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
1745.0
—
0
6
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
4.9
—
98.4
—
0
7
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3024471) HLA-A [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
66
0.91
0.00
1.0
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
5
50
1.00
0.00
2.0
1.6
—
0.1
—
0
7
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.0
—
52.4
—
0
5
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
152.4
—
0
5
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
2.8
—
93.8
—
0
6
(42529406) Shigella sp [Presence] in Stool by Culture
5
57
0.87
0.00
1.2
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
66
0.91
0.00
1.0
1.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
17.5
—
0
5
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
55
0.91
0.00
1.2
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
78
0.89
0.00
1.3
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_BRAIN_NOS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BRAIN_NOS | 1.973 [1.46, 2.67] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.021 |
During the follow-up period (1.1.1998 — 31.12.2019), 87 out of 375 females with CD2_BENIGN_BRAIN_NOS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BRAIN_NOS | 1.925 [1.33, 2.79] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.015 |
During the follow-up period (1.1.1998 — 31.12.2019), 59 out of 249 males with CD2_BENIGN_BRAIN_NOS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_BRAIN_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.144% | 0.407% |
| 5 | 1.001% | 2.468% |
| 10 | 2.701% | 5.618% |
| 15 | 4.635% | 10.786% |
| 20 | 7.798% | 17.817% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BRAIN_NOS – Benign neoplasm: Brain, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data